Jade Biosciences (JBIO) Treasury Shares (2022 - 2026)

Jade Biosciences has reported Treasury Shares for 5 years, with the latest figure at $307142.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares changed N/A year-over-year to $307142.0; the trailing twelve-month figure through Mar 2026 stood at $307142.0 (changed N/A YoY), and the FY2025 full-year result was $339473.0, down 34.38% from the prior year.
• Treasury Shares for Q1 2026 stood at $307142.0, down from $339473.0 in the prior quarter.
• The five-year high for Treasury Shares was $28.9 million in Q4 2022, with the low at $1631.0 in Q2 2022.
• Historically, Treasury Shares has averaged $2.4 million across 5 years, with a median of $31881.0 in 2023.
• Annual changes were most pronounced in 2023 — Treasury Shares tumbled 99.92% — and 2024, when it jumped 2254.76%.
• Jade Biosciences' Treasury Shares stood at $28.9 million in 2022, then plunged by 99.92% to $21968.0 in 2023, then jumped by 2254.76% to $517293.0 in 2024, then plunged by 34.38% to $339473.0 in 2025, then decreased by 9.52% to $307142.0 in 2026.
• The last three Treasury Shares figures came in at $307142.0 (Q1 2026), $339473.0 (Q4 2025), and $371804.0 (Q3 2025), per Business Quant data.